It was recently demonstrated that next generation sequencing (NGS) targeting the coding regions of the DYSF gene enables efficient and accurate genetic diagnosis of dysferlinopathy [10]. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.